UK markets closed

GenSight Biologics S.A. (0RIM.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
3.4580+0.1100 (+3.29%)
At close: 05:50PM BST
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.64
52-week change 3N/A
S&P500 52-week change 3-16.45%
52-week high 33.4580
52-week low 33.4080
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 524.38M
Implied shares outstanding 6N/A
Float 830.78M
% held by insiders 114.80%
% held by institutions 136.46%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 Jun 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-658.59%

Management effectiveness

Return on assets (ttm)-38.76%
Return on equity (ttm)-171.90%

Income statement

Revenue (ttm)5.08M
Revenue per share (ttm)0.11
Quarterly revenue growth (yoy)-38.20%
Gross profit (ttm)7.71M
EBITDA -33.47M
Net income avi to common (ttm)-31.03M
Diluted EPS (ttm)-0.6330
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)24.15M
Total cash per share (mrq)0.52
Total debt (mrq)16.09M
Total debt/equity (mrq)502.34
Current ratio (mrq)1.88
Book value per share (mrq)0.07

Cash flow statement

Operating cash flow (ttm)-23.61M
Levered free cash flow (ttm)-21.55M